A Relative Bioavailability Study to Compare the Pharmacokinetics of a Fixed Dose Combination of Fluticasone Furoate and Levocabastine With Levocabastine and Fluticasone Furoate Alone
Phase of Trial: Phase I
Latest Information Update: 19 May 2017
Price : $35 *
At a glance
- Drugs Fluticasone furoate/levocabastine (Primary) ; Fluticasone furoate; Levocabastine
- Indications Allergic conjunctivitis; Asthma; Perennial allergic rhinitis; Rhinosinusitis; Seasonal allergic rhinitis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 13 Mar 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 06 Mar 2014 According to the ClinicalTrials.gov record, status changed from recruiting to active, no longer recruiting.
- 22 Oct 2013 New trial record